Dr.Koji Iwasaki is the Professor of Academic Clinical Research Center, Osaka University Hospital. Dr. Iwasaki is incharge of progress of clinical research, specially, building the strategy, clarify the hypothesis and creating the protocol for clinical trial with investigators in reserch team. Dr. Iwasaki has over 30 years' clinical development experience in the pharmaceutical company, including clinical research and reguratory science. Dr. Iwasaki has experience in setting up medical affairs departments in pharmaceutical companies and he is the organizer of the Medical Affairs Certification Training Program of the Regulatory Science Foundation. Dr. Iwasaki holds a PhD in Pharmaceutical science from Kyoto Pharmaceutical University.

Mr. Koichi Konno is a chief executive at PM consulting Positive Intention. Mr. Konno has started his career as a consultant of project management in 2013. He has over ten years of experience as a manager of PMO, after 10 years of working as a leader of clinical study in a pharmaceutical company. Mr. Konno holds certification of Project Management Professional (PMP) and he is a lead of Project Management Community of DIA Japan.

Takashi Sato brings over 30 years of pharmaceutical R&D experience to his current role supporting translational research as an ARO Project Manager. With a background in discovery research, clinical pharmacovigilance, and CRA field operations at pharmaceutical companies, he leverages deep practitioner insights to manage complex development projects. Holding both PMP and CPCC credentials, he combines project management methodology with certified executive coaching. As an independent practitioner, he offers specialized PM training, consulting, and one-on-one coaching.

Mr. Shuji Sumida is Senior Director, HR Business Partner of Quality & Regulatory Compliance Unit at CHUGAI PHARMACEUTICAL CO., LTD. In this position, Mr. Sumida is a responsible person for HR strategy containing hiring, rotation and carrier development in that division. Mr. Sumida has over 35 years' experience in the pharmaceutical industries, including Formulation Technology, Project Management, and Quality & Regulatory Compliance. Mr. Sumida holds a MSc in Pharmacoscience from Tokyo University of Science and a Project Management Specialist from PMAJ.

Atsushi Tsukamoto is Senior Executive Officer and Head of Corporate Strategy at Daiichi Sankyo Co., Ltd. After nearly 20 years in global project management in Japan and the US, he headed Japan New Drug Regulatory Affairs from 2018, also leading global specialty medicine regulatory strategy. In 2022 he moved to Daiichi Sankyo, Inc. (US) as Head of Therapeutic Area Strategies, then took on corporate strategy in 2025. He holds a PhD in Drug Development from Kitasato University.